These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7699576)

  • 1. Digoxin-specific Fab fragments impair renal function in the rat.
    Moran RJ; Struthers AD; Hewick DS
    J Pharm Pharmacol; 1994 Oct; 46(10):854-6. PubMed ID: 7699576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal tolerance of digoxin-specific Fab fragments in the rat.
    Advenier E; Mouajjah S; Bazin-Redureau M; Launay JM; Scherrmann JM
    Toxicology; 1998 Apr; 126(3):223-9. PubMed ID: 9674970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of an enzyme-linked immunosorbent assay to study the disposition of sheep digoxin-specific immunoglobulin G and Fab fragments in the rat.
    Johnston PC; Stevenson IH; Hewick DS
    Clin Exp Immunol; 1988 Dec; 74(3):489-93. PubMed ID: 3233793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The plasma kinetics of digoxin-specific Fab fragments and digoxin in the rabbit.
    Timsina MP; Hewick DS
    J Pharm Pharmacol; 1991 Nov; 43(11):807-10. PubMed ID: 1686913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The plasma disposition and renal elimination of digoxin-specific Fab fragments and digoxin in the rabbit.
    Timsina MP; Hewick DS
    J Pharm Pharmacol; 1992 Oct; 44(10):796-800. PubMed ID: 1360503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time- and dose-dependent digoxin redistribution by digoxin-specific antigen binding fragments in a rat model.
    Renard C; Weinling E; Pau B; Scherrmann JM
    Toxicology; 1999 Sep; 137(2):117-27. PubMed ID: 10521148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic aspects of digoxin-specific Fab therapy in the management of digitalis toxicity.
    Ujhelyi MR; Robert S
    Clin Pharmacokinet; 1995 Jun; 28(6):483-93. PubMed ID: 7656506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digoxin-specific Fab fragments impair renal function in the rabbit.
    Timsina MP; Hewick DS
    J Pharm Pharmacol; 1992 Oct; 44(10):867-9. PubMed ID: 1360517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity and kinetics of distribution and elimination of sheep digoxin-specific IgG and Fab fragments in the rabbit and baboon.
    Smith TW; Lloyd BL; Spicer N; Haber E
    Clin Exp Immunol; 1979 Jun; 36(3):384-96. PubMed ID: 114346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of enzyme-linked immunosorbent assays to study the plasma disposition of sheep polyclonal and rat monoclonal digoxin-specific Fab fragments in the rabbit.
    Timsina MP; Hewick DS
    J Pharm Pharmacol; 1990 Aug; 42(8):572-6. PubMed ID: 1981586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of digoxin-specific Fab: effects of decreased renal function and age.
    Renard C; Grene-Lerouge N; Beau N; Baud F; Scherrmann JM
    Br J Clin Pharmacol; 1997 Aug; 44(2):135-8. PubMed ID: 9278197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind, placebo-controlled trial of the effects of prophylactic theophylline on renal function in term neonates with perinatal asphyxia.
    Jenik AG; Ceriani Cernadas JM; Gorenstein A; Ramirez JA; Vain N; Armadans M; Ferraris JR
    Pediatrics; 2000 Apr; 105(4):E45. PubMed ID: 10742366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of digoxin-specific antibody fragments on digoxin disposition in the rat.
    Johnston PC; Stevenson IH; Hewick DS
    Biochem Pharmacol; 1987 Jul; 36(13):2215-20. PubMed ID: 3606637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics in renally impaired subjects of NXY-059, a nitrone-based, free-radical trapping agent developed for the treatment of acute stroke.
    Strid S; Borgå O; Edenius C; Jostell KG; Odergren T; Weil A
    Eur J Clin Pharmacol; 2002 Sep; 58(6):409-15. PubMed ID: 12242600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fab-bound colchicine appears to adopt Fab fragment disposition in rats.
    Sabouraud AE; Urtizberea M; Benmoussa K; Cano NJ; Scherrmann JM
    J Pharm Pharmacol; 1992 Dec; 44(12):1015-9. PubMed ID: 1361548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effects of selective and non-selective nitric oxide synthase inhibition in gentamicin-induced rat nephrotoxicity.
    Ghaznavi R; Kadkhodaee M
    Arch Toxicol; 2007 Jun; 81(6):453-7. PubMed ID: 17039356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal effects of bicarbonate versus saline infusion for iso- and lowosmolar contrast media in rats.
    Ladwig M; Flemming B; Seeliger E; Sargsyan L; Persson PB
    Invest Radiol; 2011 Nov; 46(11):672-7. PubMed ID: 21623210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digoxin-specific antibody fragments in the treatment of digoxin toxicity.
    Chan BS; Buckley NA
    Clin Toxicol (Phila); 2014; 52(8):824-36. PubMed ID: 25089630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments. Final report of a multicenter study.
    Antman EM; Wenger TL; Butler VP; Haber E; Smith TW
    Circulation; 1990 Jun; 81(6):1744-52. PubMed ID: 2188752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digoxin-specific Fab fragments in the treatment of oleander toxicity in a canine model.
    Clark RF; Selden BS; Curry SC
    Ann Emerg Med; 1991 Oct; 20(10):1073-7. PubMed ID: 1928877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.